Unit:
Mawei Town
Project Area:
Fuzhou Mawei Town
Industry:
Biological and New Pharmaceutical Industry
Type of Project:
New Project
Cooperation Mode:
Collaborate
Nature of Project:
Permit
Working Progress in Prior Period:
none
Total Investment:
300 million yuan
Expected to Attract Investment:
300 million yuan
Content and Scale:
Fujian Shangzhongda Bioengineering Co., Ltd. and Fuzhou Xie'ai Hospital make full use of the advantages of Fujian Free Trade Zone (Fuzhou) area, unite experts and science and technology enterprises in the province, and introduce Taiwan expert teams and science and technology enterprises to jointly set up the "Free Trade Zone Biomedical Clinical Translational Research Platform Project" (including "Clinical Medical Research Base" and "GMP Biological Laboratory") in Fuzhou Xie'ai Hospital to carry out a series of forward-looking and innovative clinical research and develop the life and health industry.
Industry

Biological & New Pharmaceutical Industry

In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.